SOX2 and urinary bladder carcinoma: SOX2 expression had been shown as a potential CSC marker in bladder cancers (BCa) where SOX2-expressing cells could seed the BCa, and lineage-specific ablation of SOX2-expressing cells enhanced tumor regression (Zhu et al., 2017).